Thcrc 3rc two other ispccts in thc nianagcment orasthma in this counrry t h a t nccd to bc qucstioncd - namcly thc role
prcxnr plan to include not only a n accurate diagnosis and adequate invcsrigation bur also total care for cvcry pa:icnr.l)
ofdrug comp3nics and !he submission ofarticlcs to mcdical
R. MUNRO FORD, Emeritus Consultant Physician, Royal Adelaide Hospital. now of Southport, Q D .
journals.
A liiilc whilc 390 wc saw thc specraclc of two authorities urging thc nccd for caution with rcgard to B2 agonkts. However, following an approach by o drug company, thcy changed their mcrsagc to rcad thar ‘there I no doubt abour the safety ofall ofthcm’. Drug compania have made many worthwhile contributions to thc management of asthma in this country sponsoring scholarships, rcxarch projms, symposia fw Royal Wkges and &&tics c t c bur we ShOuM never forget tbe fan that there is no such thing as a ‘fret
References 1. Sale JP.Asthma darhsr whcrc arc we now? Aurt NZ j Mcd 1991;31: 6789. 2. Ryan G , Musk AW, Pcrcra DM cr d. Risk fact- GN datb in paticntr admined to bospinlvirh athrm:a h l h v up study. A m
NZ J Mrd 1991; 21: 681-5. 3. M z y R, P e v a N,Cranel a d k h m r monalhyad iahakd beta agonk thmpy. A m NZ J Mcd 1991; 21: 753-61.
lunch’. F i l l y , we have the pncticc ofeditors rcfrrring submitted utidu, wen simplc letters, to cxpcn referees who ifthey disagree with their contents, or ifthey thausdvcs arc aiticiscd, will ensure thai they n c v u reach tbe tight of day. U n f o r m n a t e l y ~j€fumdsucthcoalyfmumthat m y dicians have to u p r a t their viewr. The bucasing incidence and dath rates fram asthma in this country surely demands that we shcmld broaden our
4. M u n r o F o r d R E r i d n n h m r A c o n t i n u i n g m i c w . h n n of Allergy 1983; u): 47-50. 5. Robcruon CF, Haycock E,Bishop J er uL P r d Ocpthmr in Mclbaurnc school childFaL Q u t p o v a 26 yeus. Br Mad
J 1991; M2r I l l a a 6. SpiUtr WO, Suiw S,
Ermt P a d A nested cumd studyof thcrdrdonbmtm B-8geniscs.bddegbanar darbfrom ostbma. Lcchur to Tbor SocA & NZ 1991; Scpemaz 3.
-
Breast cancer treatment outside teaching hospitals A rccept h e r tothe Lamr’r c p o r t a i ~ d i E ~for cure in early stage disease and probagation ofswvivd in Rwival krwem patienu treated for early ragc ovarian in metutpticdiscvc T s l r o g r o u p s o f WcRcoIlSidcIDd ~ .MCU in teaching hospitals WS~EInon-ccaching barpirrlr -tba6epsithsclgr in ScntIad I f this trend were g c n d k e d to othtr f;onnr 2 disasc d e n e d for xijuvmt t€laapy md those Wi& . ofcmcxr therapy it wouid haw important i m p ~ f b r w u n a t i c ~ ~ t c d ~ ~ P. .a t . i u u andwullldisePerpedficurddapsc6ccsuzvivduthrcc the Apltrplion setting where vast diumccsdooat.tbrdl yeus arc sbown in Tabk 1 far stage 2. patients 10 rcccin dl oftbdr IrmmalCirrtadlingbwpi9lt. Tbuc was no signiticpnr M iin outmme krwctn onerespoosc to such wilcuna has bccntbcdtpebpmmt o f ~ o c n r i c a i n l v g a r c g i o r u l ~ ~ ~ n u the n t two uc?tmQItanvCr(L0gulkp> o*oq. Tbcsl lc3ub arc comparable to t k rcpwncd roccLltlp in the ovcnkw specirlisulad visited regutarty by teaching aospitpl mcdof systcmic treatment ofearly brast cam& fk trmoxifm ogists fix rbt of patients a d t h Ippavirioa of or polychanothcnpy in randomid &Is. chcmotbcmpy;Pdminir~don site O w d s e r v i a inNcw Median suMval from the time ofmetosrois was uxd as South Wala has k n in operation since 1985 and pmmpcd a measure of a a c y ofpallttivc tbeapy in 146 patients by the lcttcr referred to above, wc have audited our prticnts treated for metastatic disasc Thc perrrntrgc ofparicnts in with brcw cancer r r a t c d in 1987188 and compared nuriVa1 at thrcc yean wirh similar patients rratcd in our teaching each group with a short disease fm intuval is shown in Tabk hospital Breast cancer was chasen rather than ovarian cancer 2 below, as this was the major @aor of poor prognosis largely because of patient numbers, but shares with ovarian in the ovenll group (DFI
prcxnr plan to include not only a n accurate diagnosis and adequate invcsrigation bur also total care for cvcry pa:icnr.l)
ofdrug comp3nics and !he submission ofarticlcs to mcdical
R. MUNRO FORD, Emeritus Consultant Physician, Royal Adelaide Hospital. now of Southport, Q D .
journals.
A liiilc whilc 390 wc saw thc specraclc of two authorities urging thc nccd for caution with rcgard to B2 agonkts. However, following an approach by o drug company, thcy changed their mcrsagc to rcad thar ‘there I no doubt abour the safety ofall ofthcm’. Drug compania have made many worthwhile contributions to thc management of asthma in this country sponsoring scholarships, rcxarch projms, symposia fw Royal Wkges and &&tics c t c bur we ShOuM never forget tbe fan that there is no such thing as a ‘fret
References 1. Sale JP.Asthma darhsr whcrc arc we now? Aurt NZ j Mcd 1991;31: 6789. 2. Ryan G , Musk AW, Pcrcra DM cr d. Risk fact- GN datb in paticntr admined to bospinlvirh athrm:a h l h v up study. A m
NZ J Mrd 1991; 21: 681-5. 3. M z y R, P e v a N,Cranel a d k h m r monalhyad iahakd beta agonk thmpy. A m NZ J Mcd 1991; 21: 753-61.
lunch’. F i l l y , we have the pncticc ofeditors rcfrrring submitted utidu, wen simplc letters, to cxpcn referees who ifthey disagree with their contents, or ifthey thausdvcs arc aiticiscd, will ensure thai they n c v u reach tbe tight of day. U n f o r m n a t e l y ~j€fumdsucthcoalyfmumthat m y dicians have to u p r a t their viewr. The bucasing incidence and dath rates fram asthma in this country surely demands that we shcmld broaden our
4. M u n r o F o r d R E r i d n n h m r A c o n t i n u i n g m i c w . h n n of Allergy 1983; u): 47-50. 5. Robcruon CF, Haycock E,Bishop J er uL P r d Ocpthmr in Mclbaurnc school childFaL Q u t p o v a 26 yeus. Br Mad
J 1991; M2r I l l a a 6. SpiUtr WO, Suiw S,
Ermt P a d A nested cumd studyof thcrdrdonbmtm B-8geniscs.bddegbanar darbfrom ostbma. Lcchur to Tbor SocA & NZ 1991; Scpemaz 3.
-
Breast cancer treatment outside teaching hospitals A rccept h e r tothe Lamr’r c p o r t a i ~ d i E ~for cure in early stage disease and probagation ofswvivd in Rwival krwem patienu treated for early ragc ovarian in metutpticdiscvc T s l r o g r o u p s o f WcRcoIlSidcIDd ~ .MCU in teaching hospitals WS~EInon-ccaching barpirrlr -tba6epsithsclgr in ScntIad I f this trend were g c n d k e d to othtr f;onnr 2 disasc d e n e d for xijuvmt t€laapy md those Wi& . ofcmcxr therapy it wouid haw important i m p ~ f b r w u n a t i c ~ ~ t c d ~ ~ P. .a t . i u u andwullldisePerpedficurddapsc6ccsuzvivduthrcc the Apltrplion setting where vast diumccsdooat.tbrdl yeus arc sbown in Tabk 1 far stage 2. patients 10 rcccin dl oftbdr IrmmalCirrtadlingbwpi9lt. Tbuc was no signiticpnr M iin outmme krwctn onerespoosc to such wilcuna has bccntbcdtpebpmmt o f ~ o c n r i c a i n l v g a r c g i o r u l ~ ~ ~ n u the n t two uc?tmQItanvCr(L0gulkp> o*oq. Tbcsl lc3ub arc comparable to t k rcpwncd roccLltlp in the ovcnkw specirlisulad visited regutarty by teaching aospitpl mcdof systcmic treatment ofearly brast cam& fk trmoxifm ogists fix rbt of patients a d t h Ippavirioa of or polychanothcnpy in randomid &Is. chcmotbcmpy;Pdminir~don site O w d s e r v i a inNcw Median suMval from the time ofmetosrois was uxd as South Wala has k n in operation since 1985 and pmmpcd a measure of a a c y ofpallttivc tbeapy in 146 patients by the lcttcr referred to above, wc have audited our prticnts treated for metastatic disasc Thc perrrntrgc ofparicnts in with brcw cancer r r a t c d in 1987188 and compared nuriVa1 at thrcc yean wirh similar patients rratcd in our teaching each group with a short disease fm intuval is shown in Tabk hospital Breast cancer was chasen rather than ovarian cancer 2 below, as this was the major @aor of poor prognosis largely because of patient numbers, but shares with ovarian in the ovenll group (DFI
